BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23744124)

  • 21. Symptomatic leptomeningeal carcinomatosis: a rare presentation of chronic lymphocytic leukaemia relapse.
    Batayneh O; Lin A; Abu-Jaradeh O; Wu P; Villamar MF; Sharma P
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35675961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of signal shadowing during intraoperative optical coherence tomography-assisted vitreoretinal surgery.
    Carlos Reyna E; Öztek M; Petrovski G; Binder S; Stieger K; Lytvynchuk L
    Sci Rep; 2024 Mar; 14(1):5393. PubMed ID: 38443491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature.
    de Souza SL; Santiago F; Ribeiro-Carvalho Mde M; Arnóbio A; Soares AR; Ornellas MH
    BMC Res Notes; 2014 Sep; 7():645. PubMed ID: 25218117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitreous substitutes: the present and the future.
    Donati S; Caprani SM; Airaghi G; Vinciguerra R; Bartalena L; Testa F; Mariotti C; Porta G; Simonelli F; Azzolini C
    Biomed Res Int; 2014; 2014():351804. PubMed ID: 24877085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Analysis of Liquid Vitreous Biopsy Reveals Occult Lymphoma Following Cytology-Negative Biopsies of the Brain and Vitreous.
    Balikov DA; Conway K; Brown NA; Camelo-Piragua S; Rao RC
    Ocul Immunol Inflamm; 2023 Dec; ():1-9. PubMed ID: 38109211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted therapy in ophthalmic oncology: The current status.
    Sen M; Demirci H; Honavar SG
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100062. PubMed ID: 38642707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Staging and systemic treatment of ocular and periocular metastases].
    Dörfel D; Babst N; Heindl LM; Kakkassery V; Müller MR
    Ophthalmologie; 2024 May; 121(5):374-381. PubMed ID: 38683363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of an Unusual Bleeder: Small Bowel Lymphoma.
    Zaher EA; Ebrahim MA; Patel P; Zaher D; Talib M
    Cureus; 2024 May; 16(5):e59448. PubMed ID: 38826993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series.
    Lamacki AJ; Montag C; Kertowidjojo E; Diane Yamada S; Kurnit KC
    Gynecol Oncol Rep; 2024 Jun; 53():101409. PubMed ID: 38757117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Unique Presentation of Diffuse Large B-Cell Lymphoma Involving the Central Nervous System.
    Lim JM; Patel RM; Aakalu VK; Setabutr P
    Neuroophthalmology; 2013; 37(4):169-171. PubMed ID: 28167983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding and Classification of Ocular Lymphomas.
    White VA
    Ocul Oncol Pathol; 2019 Oct; 5(6):379-386. PubMed ID: 31768360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferons in vitreoretinal diseases; a review on their clinical application, and mechanism of action.
    Afarid M; Azimi A; Meshksar A; Sanie-Jahromi F
    Int Ophthalmol; 2024 May; 44(1):223. PubMed ID: 38727788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillance.
    Wight J; Blombery P; Lickiss J; Burgess M; Gould C; Minson A; Swain F; Sabdia MB; Gandhi MK; Birchley A; Keane C; Hawkes EA
    Haematologica; 2024 Mar; ():. PubMed ID: 38511272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
    Hashida N; Nakai K; Saitoh N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.
    Abu Samra K; Oray M; Ebrahimiadib N; Lee S; Anesi S; Foster CS
    Ocul Immunol Inflamm; 2018; 26(3):347-352. PubMed ID: 27438792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual case report of primary vitreoretinal lymphoma.
    Tan SZ; Steeples LR; Chhabra R; Jones NP
    BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary intraocular lymphoma.
    Sagoo MS; Mehta H; Swampillai AJ; Cohen VM; Amin SZ; Plowman PN; Lightman S
    Surv Ophthalmol; 2014; 59(5):503-16. PubMed ID: 24560125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreoretinal lymphoma, secondary to non-CNS systemic lymphoma, masquerading as an infectious retinitis.
    Reddy V; Winslow R; Cao JH; Robertson ZM; Chen B; Ufret-Vincenty RL
    Am J Ophthalmol Case Rep; 2019 Dec; 16():100545. PubMed ID: 31468000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.
    Venkatesh R; Bavaharan B; Mahendradas P; Yadav NK
    Clin Ophthalmol; 2019; 13():353-364. PubMed ID: 30858685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.